A Phase I Study of AC0010 in Patients With CLL/ SLL, MCL, DLBCL and Other NHL
Clinical trial NCT03060850 · UNKNOWN
Trial details
- NCT number
- NCT03060850
- Sponsor
- Hangzhou ACEA Pharmaceutical Research Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-17
- Primary completion
- 2019-12-14
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.